Correlation of dose to pelvic bone and decline in bone mineral density using computed tomography in patients of carcinoma cervix treated with definitive chemoradiation
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2025
Project Lead
Jayalekshmi R
Authors
Jayalekshmi R, Avinash H Udayashankara
Project Status
completed
Project Type
Retrospective Observational Study